Journal article
Understanding the feasibility and implications of implementing early peanut introduction for prevention of peanut allergy
JJ Koplin, RL Peters, SC Dharmage, L Gurrin, MLK Tang, AL Ponsonby, M Matheson, A Togias, G Lack, KJ Allen, M Wake, A Lowe, D Hill
Journal of Allergy and Clinical Immunology | MOSBY-ELSEVIER | Published : 2016
Abstract
Background A recent randomized trial (the Learning Early About Peanut Allergy [LEAP] study) provided evidence that earlier dietary peanut introduction reduces peanut allergy prevalence in high-risk infants. However, questions remain as to how to identify and target the “at-risk” population to facilitate timely introduction of peanut. Objective We sought to use population-based infant peanut allergy data to understand feasibility and implications of implementing the LEAP trial intervention. Methods Using the HealthNuts study cohort (n = 5276) of 1-year-old infants, we explored the impact of using various criteria to identify infants at high risk of developing peanut allergy, and the implicati..
View full abstractGrants
Funding Acknowledgements
This work was supported by funding from the National Health & Medical Research Council (NHMRC) of Australia, Australian Food Allergy Foundation, Anaphylaxi-Stop, and the Victorian Government's Operational Infrastructure Support Program. The study sponsors had no involvement in the study design, collection, analysis, and interpretation of data, writing of the report, or decision to submit the article for publication.